These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 15910496)
1. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Shimazaki T; Honda M; Kaneko S; Kobayashi K Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977 [TBL] [Abstract][Full Text] [Related]
3. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250 [TBL] [Abstract][Full Text] [Related]
4. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514 [TBL] [Abstract][Full Text] [Related]
5. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587 [TBL] [Abstract][Full Text] [Related]
6. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. Jarczak D; Korf M; Beger C; Manns MP; Krüger M FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954 [TBL] [Abstract][Full Text] [Related]
7. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro. Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270 [TBL] [Abstract][Full Text] [Related]
8. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272 [TBL] [Abstract][Full Text] [Related]
9. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation. Pudi R; Ramamurthy SS; Das S J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945 [TBL] [Abstract][Full Text] [Related]
10. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176 [TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels. Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of the interferon alpha response against hepatitis C virus replicons. Guo JT; Sohn JA; Zhu Q; Seeger C Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387 [TBL] [Abstract][Full Text] [Related]
14. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon]. Jia YT; Wei L; Jiang D; Cong X; Fei R Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756 [TBL] [Abstract][Full Text] [Related]
15. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA. Paek KY; Kim CS; Park SM; Kim JH; Jang SK J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733 [TBL] [Abstract][Full Text] [Related]
16. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment. Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259 [TBL] [Abstract][Full Text] [Related]
17. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation. Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705 [TBL] [Abstract][Full Text] [Related]
18. Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3. Yasmeen A; Hamid S; Granath FN; Lindström H; Elliott RM; Siddiqui AA; Persson MA J Viral Hepat; 2006 Feb; 13(2):87-95. PubMed ID: 16436126 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides. Li X; Mueller S; Wimmer E Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092 [TBL] [Abstract][Full Text] [Related]
20. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]